我国各省基本药物招标采购制度中药品价格控制策略的比较  

Comparison of Price Control Strategies among Provincial Essential Medicine Bidding Systems in China

作　　者：洪兰[1] 贡庆[1] 叶桦[1] 

机构地区：[1]复旦大学药学院药事管理教研室,上海201203

出　　处：《中国药房》2013年第44期4148-4150,共3页China Pharmacy

摘　　要：目的:提高现有基本药物招标价格的合理性。方法:采用文献研究法,比较分析全国30个省(市)基本药物招标采购方案中的价格控制规定。结果:大部分省份在招标评审时实行的是最低价中标,各省限价依据标准不一,没有设定价格底线。结论:应进一步探索质量和价格同时兼顾的综合评价体系,在限价依据中增设指导性底价,以制定更为科学的限价原则。OBJECTIVE： To improve the rationality of bidding price of essential medicines. METHODS： The price control standards of essential medicine bidding purchase plans from 30 provinces were analyzed comparatively by literature method. RESULTS： The standard of business bid review in most of the provinces was the lowest price. Without setting bottom line price, provincial limit price standards were different. CONCLUSIONS： It is suggested to further explore comprehensive evaluation system based on technical bid and business bid, establish the guiding bottom price and develop more scientific limited price principle.

关 键 词：基本药物 招标采购 价格控制 

分 类 号：R95[医药卫生—药学]